In 2026, the pharmaceutical industry is experiencing a true renaissance: new molecules, biosimilars, and medical devices are entering the market faster than ever. But behind every successful registration lies the meticulous work of a regulatory affairs specialist. Errors in the dossier, non-compliance with FDA or EMA requirements, incorrect eCTD format—all of these can delay product launch for years.
The course 'FDA/EMA — Regulatory Affairs for Pharmaceuticals' on the Asibiont platform is your chance to master the full cycle of drug and medical device registration. In this article, I will explain why regulatory affairs is one of the most sought-after competencies in pharma, what you will learn in the course, and how AI-based learning on Asibiont helps you master complex topics faster.
Why Regulatory Affairs is a Must-Have Skill for Pharmacists
Regulatory requirements for drugs and medical devices are constantly tightening. The FDA (U.S. Food and Drug Administration) and EMA (European Medicines Agency) release dozens of new guidelines each year. For example, in 2025, the FDA updated stability data requirements for ANDAs, and the EMA updated environmental risk assessment requirements. Without understanding these nuances, it is impossible to successfully pass an inspection or obtain approval.
According to IQVIA's 2025 report, demand for regulatory affairs specialists has grown by 18% over two years, and the average salary in this field in Russia and the CIS exceeds 200,000 rubles per month. The course on Asibiont provides exactly the practical skills employers need: from dossier preparation to communication with inspectors.
What You Will Learn in the Course
The program covers the key stages of registration for the U.S. and European markets. You will master:
- Collecting and structuring documents for IND, NDA, ANDA, 510(k), PMA, and EU MDR. You will learn which reports and protocols are mandatory and which can be omitted.
- eCTD format (Electronic Common Technical Document)—the standard for submitting dossiers to the FDA and EMA. The course covers requirements for modules, navigation, and validation.
- GMP/GLP/GCP requirements—how to prepare production, laboratory, and clinical trials for inspection.
- Post-marketing monitoring—safety reports, dossier changes, registration renewal.
Here is a real-life example: a company is launching a new generic drug. Without regulatory affairs knowledge, you could spend a year collecting documents and still get rejected due to incomplete bioequivalence data. In the course, you will learn how to avoid such mistakes.
How Learning Works on Asibiont
Asibiont is a platform with an AI assistant that generates personalized lessons for each student. You do not receive a standard PDF or webinar recording. The neural network analyzes your level, goals, and pace to offer exactly the materials you need at that moment.
Learning is entirely text-based—no video lessons. This is convenient: you read lessons at any time, revisit complex topics, and take notes. The AI assistant explains complex regulatory concepts in simple language, provides real-world examples, and gives practical assignments. For example, you can ask the neural network to generate a letter template for the EMA or check the structure of an eCTD dossier.
Access to the course is available 24/7. You choose how much time to dedicate to studying—whether 15 minutes a day or 4 hours.
Why AI-Based Learning is Effective
Traditional courses often have one flaw: they do not account for your experience. If you are a beginner, you need more explanations of basic terms. If you have already worked with the FDA, you need advanced nuances. AI on Asibiont solves this problem:
- The neural network adapts the program to your level. If you do not know what a 'risk management plan' is, the AI will show an example from the ICH Q9 guideline. If you are an expert, it will suggest analyzing a case with inspection observations.
- Explanation of complex topics—without convoluted wording. The AI can translate regulatory language into understandable human terms.
- Answers to questions directly during the learning process. You can ask: 'What documents are needed for a 510(k) for a Class II medical device?'—and the AI will give a structured answer with links to official sources.
This approach has proven effective: according to Asibiont's internal surveys, 85% of students note that the AI assistant reduces the time to learn a topic by 2-3 times compared to self-study of regulations.
Who This Course is For
The course 'FDA/EMA — Regulatory Affairs for Pharmaceuticals' will be useful for:
- Registration specialists (regulatory affairs specialists) who want to systematize their knowledge or move to an international level.
- Quality and GMP managers—to understand how production requirements affect the dossier.
- Beginning pharmacists and pharmacy graduates planning a career in regulatory affairs.
- Entrepreneurs in MedTech—if you are bringing a medical device to the U.S. or EU market, the course will save you months.
Whether you work in a large corporation or a startup, the skills gained in the course are applicable in any company involved in export or local registration.
Conclusion
Regulatory affairs is not just bureaucracy. It is a science that saves lives: without FDA or EMA approval, no drug reaches patients. The course 'FDA/EMA — Regulatory Affairs for Pharmaceuticals' on Asibiont gives you the tools to become an expert in this field. AI-based learning makes the process fast, flexible, and personalized.
Do not postpone your career growth. Start learning today—go to the course page FDA/EMA — Regulatory Affairs for Pharmaceuticals and get access to a program that will change your understanding of regulatory affairs.
Comments